Recently, Raycision was invited to attend The 2nd International Symposium on Chemical & Biomedical Imaging (CBMI-II) in Hong Kong. The symposium brought together experts and researchers from universities, research institutions, and industry around the world to exchange insights on emerging advances in chemical imaging, biomedical imaging, and related fields.
During the symposium, Raycision engaged in face-to-face technical discussions with experts and researchers from across the globe. Focusing on high-resolution imaging, multimodality imaging, and in vivo imaging, the team shared Raycision’s latest technological advances and application cases in the field of preclinical imaging.
Raycision was also invited to deliver a dedicated academic presentation, highlighting the company’s latest innovations in micro-CT, optical molecular imaging, and multimodality imaging platforms. Closely aligned with practical research needs, the presentation demonstrated the important role of advanced imaging technologies in areas such as cancer research, drug evaluation, and disease model development, attracting strong interest and encouraging in-depth discussions among attending experts.
For Raycision, the symposium was more than an opportunity for international academic exchange; it also provided a valuable platform to explore the future of life sciences together with researchers from around the world. Looking ahead, Raycision will remain committed to technological innovation and to advancing the integration of high-end imaging technologies with life science research, providing researchers worldwide with more precise and efficient imaging solutions.
